Waning economic growth could dent the market rally in the near term before more realistic earnings estimates boost the S&P 500 to new highs, according to UBS.
Related Posts
‘Everyone is calling’: Trump’s tariff threats send U.S. companies scrambling for lobbyists and loopholes
Donald Trump campaigned on hardline tariff proposals that alarmed economists, corporate America and Wall Street.
CVS gets an upgrade to buy from Leerink Partners after pharmacy operator’s strong earnings
CVS Health has more room to run even as the broader health care segment remains troubled, according to Leerink Partners.
These 9 biotech stocks have doubled this year and are set to double again, analysts say
The bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.